AI Drug Discovery Biz Valued At $3.8B After Series C Round

Дата публикации: 14-07-2026 16:07:24

Artificial intelligence-based drug discovery company Chai Discovery on Tuesday revealed that it reached a $3.8 billion valuation after closing its latest funding round with $400 million in tow.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	AI Drug Discovery Biz Valued At $3.8B After Series C Round	0	5	14-07-2026
2	Chai Discovery Raises $400 Million Series C To Advance AI-Driven Molecular Design	5	7	14-07-2026
3	AI drug development startup Pathos AI closes $237M investment	0	9.13	23-10-2026
4	Suno Unveils $400 Million Series D, Tees Up the Release of Its ‘First Music Model Developed in Partnership With the Music Industry’	5	7	03-06-2026
5	Insurance Tech Co. Hits $1.9B Valuation After Fundraise	0	5	14-07-2026
6	Legal AI startup Norm Ai hits $1.2 billion valuation after $120 million funding	5	7	07-07-2026
7	Lantern Pharma Says AI Cuts First-In-Human Drug Development Cost To $2 Million-$3 Million	0	12.78	15-08-2026
8	WSJ: бум компаний в сфере ИИ может обернуться новым "пузырем доткомов"	0	0	10-03-2025
9	Tencent та Alibaba планують інвестувати в DeepSeek: оцінка ШІ-стартапу перевищила млрд	5	7	27-04-2026
10	Neobanking Biz Hits $1B Valuation After Series C Round	0	15.31	24-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: www.law360.com.